Malaria — Worldwide/Unknown
Mosquirix to be used for vaccination of young children, together with established antimalarial interventions.
The European Medicines Agency’s [EMA] Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion for Mosquirix (_Plasmodium falciparum_ and hepatitis B vaccine), for use outside the European Union (EU).
The malaria vaccine Mosquirix, also known as RTS,S/AS01, was submitted to EMA under a regulatory procedure (Article 58) that allows EMA to
…
